- Home
- QIPT vs ELDN Comparison
QIPT vs ELDN Comparison
Compare QIPT & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QIPT | ELDN |
|---|---|---|
| Founded | 1993 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.2M | 166.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | QIPT | ELDN |
|---|---|---|
| Price | $3.58 | $2.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $3.83 | ★ $8.50 |
| AVG Volume (30 Days) | 438.2K | ★ 548.9K |
| Earning Date | 02-09-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $264,974,000.00 | N/A |
| Revenue This Year | $28.30 | N/A |
| Revenue Next Year | $1.79 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 8.28 | N/A |
| 52 Week Low | $1.35 | $1.35 |
| 52 Week High | $3.61 | $4.65 |
Technical Indicators
Market Signals| Indicator | QIPT | ELDN |
|---|---|---|
| Relative Strength Index (RSI) | 71.93 | 53.25 |
| Support Level | $3.55 | $1.96 |
| Resistance Level | $3.54 | $2.22 |
| Average True Range (ATR) | 0.02 | 0.15 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 87.50 | 38.67 |
Price Performance
Historical ComparisonAbout QIPT Quipt Home Medical Corp.
Quipt Home Medical Corp is a provider of durable medical equipment (DME) and home medical equipment (HME) in the United States. The Company specializes in delivering in-home treatments for the management of chronic conditions, with a primary focus on respiratory diseases, and supports patients with heart and pulmonary diseases, sleep apnea, reduced mobility, and other chronic health challenges. Its products and services include Sleep Apnea and PAP treatment, home medical equipment, home ventilation, and custom mobility solutions. The Company operates in a single business segment, comprising the sale and rental of medical equipment and related devices, and serves patients across 27 states in the United States.
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.